Free Trial

JAN (JAN) Competitors

JAN logo
$28.40 -0.45 (-1.54%)
As of 12:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

JAN vs. OHI, DOC, AHR, CTRE, and ARE

Should you buy JAN stock or one of its competitors? JAN's main competitors and comparable companies include Omega Healthcare Investors (OHI), Healthpeak Properties (DOC), American Healthcare REIT (AHR), CareTrust REIT (CTRE), and Alexandria Real Estate Equities (ARE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare reits" industry.

How does JAN compare to Omega Healthcare Investors?

JAN (NYSE:JAN) and Omega Healthcare Investors (NYSE:OHI) are both real estate companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

JAN pays an annual dividend of $0.57 per share and has a dividend yield of 2.0%. Omega Healthcare Investors pays an annual dividend of $2.72 per share and has a dividend yield of 6.0%. Omega Healthcare Investors pays out 97.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

6.3% of JAN shares are held by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are held by institutional investors. 1.7% of Omega Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Omega Healthcare Investors has a net margin of 66.96% compared to JAN's net margin of 0.00%. Omega Healthcare Investors' return on equity of 15.76% beat JAN's return on equity.

Company Net Margins Return on Equity Return on Assets
JANN/A N/A N/A
Omega Healthcare Investors 66.96%15.76%8.40%

JAN currently has a consensus target price of $32.38, suggesting a potential upside of 12.15%. Omega Healthcare Investors has a consensus target price of $49.93, suggesting a potential upside of 10.44%. Given JAN's stronger consensus rating and higher probable upside, equities analysts plainly believe JAN is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JAN
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Omega Healthcare Investors
2 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.27

Omega Healthcare Investors has higher revenue and earnings than JAN.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JAN$890.18M9.47$6.35MN/AN/A
Omega Healthcare Investors$1.19B11.51$572.03M$2.8016.15

In the previous week, JAN had 50 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 59 mentions for JAN and 9 mentions for Omega Healthcare Investors. JAN's average media sentiment score of 1.68 beat Omega Healthcare Investors' score of 0.52 indicating that JAN is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
JAN
54 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Omega Healthcare Investors
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Omega Healthcare Investors beats JAN on 9 of the 16 factors compared between the two stocks.

How does JAN compare to Healthpeak Properties?

Healthpeak Properties (NYSE:DOC) and JAN (NYSE:JAN) are both real estate companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Healthpeak Properties currently has a consensus price target of $21.80, suggesting a potential upside of 14.88%. JAN has a consensus price target of $32.38, suggesting a potential upside of 12.15%. Given Healthpeak Properties' higher probable upside, analysts clearly believe Healthpeak Properties is more favorable than JAN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Healthpeak Properties
0 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
JAN
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

Healthpeak Properties pays an annual dividend of $1.22 per share and has a dividend yield of 6.4%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 2.0%. Healthpeak Properties pays out 348.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Healthpeak Properties has higher revenue and earnings than JAN.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Healthpeak Properties$2.82B4.64$71.35M$0.3554.22
JAN$890.18M9.47$6.35MN/AN/A

Healthpeak Properties has a net margin of 8.24% compared to JAN's net margin of 0.00%. Healthpeak Properties' return on equity of 2.79% beat JAN's return on equity.

Company Net Margins Return on Equity Return on Assets
Healthpeak Properties8.24% 2.79% 1.17%
JAN N/A N/A N/A

93.6% of Healthpeak Properties shares are held by institutional investors. Comparatively, 6.3% of JAN shares are held by institutional investors. 0.2% of Healthpeak Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, JAN had 50 more articles in the media than Healthpeak Properties. MarketBeat recorded 59 mentions for JAN and 9 mentions for Healthpeak Properties. JAN's average media sentiment score of 1.68 beat Healthpeak Properties' score of 0.63 indicating that JAN is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Healthpeak Properties
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
JAN
54 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Healthpeak Properties beats JAN on 9 of the 16 factors compared between the two stocks.

How does JAN compare to American Healthcare REIT?

American Healthcare REIT (NYSE:AHR) and JAN (NYSE:JAN) are both real estate companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

American Healthcare REIT currently has a consensus price target of $62.00, indicating a potential upside of 18.12%. JAN has a consensus price target of $32.38, indicating a potential upside of 12.15%. Given American Healthcare REIT's stronger consensus rating and higher probable upside, equities analysts clearly believe American Healthcare REIT is more favorable than JAN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.07
JAN
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

In the previous week, JAN had 56 more articles in the media than American Healthcare REIT. MarketBeat recorded 59 mentions for JAN and 3 mentions for American Healthcare REIT. JAN's average media sentiment score of 1.68 beat American Healthcare REIT's score of 0.67 indicating that JAN is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
American Healthcare REIT
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
JAN
54 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

16.7% of American Healthcare REIT shares are owned by institutional investors. Comparatively, 6.3% of JAN shares are owned by institutional investors. 0.8% of American Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

American Healthcare REIT has higher revenue and earnings than JAN.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Healthcare REIT$2.26B5.06$69.81M$0.6877.19
JAN$890.18M9.47$6.35MN/AN/A

American Healthcare REIT pays an annual dividend of $1.00 per share and has a dividend yield of 1.9%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 2.0%. American Healthcare REIT pays out 147.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

American Healthcare REIT has a net margin of 4.84% compared to JAN's net margin of 0.00%. American Healthcare REIT's return on equity of 3.63% beat JAN's return on equity.

Company Net Margins Return on Equity Return on Assets
American Healthcare REIT4.84% 3.63% 2.25%
JAN N/A N/A N/A

Summary

American Healthcare REIT beats JAN on 9 of the 14 factors compared between the two stocks.

How does JAN compare to CareTrust REIT?

CareTrust REIT (NYSE:CTRE) and JAN (NYSE:JAN) are both mid-cap real estate companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

CareTrust REIT has higher earnings, but lower revenue than JAN.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareTrust REIT$476.39M18.12$320.54M$1.5922.98
JAN$890.18M9.47$6.35MN/AN/A

87.8% of CareTrust REIT shares are held by institutional investors. Comparatively, 6.3% of JAN shares are held by institutional investors. 0.7% of CareTrust REIT shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

CareTrust REIT has a net margin of 62.19% compared to JAN's net margin of 0.00%. CareTrust REIT's return on equity of 8.52% beat JAN's return on equity.

Company Net Margins Return on Equity Return on Assets
CareTrust REIT62.19% 8.52% 6.64%
JAN N/A N/A N/A

CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.3%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 2.0%. CareTrust REIT pays out 98.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT has increased its dividend for 3 consecutive years. CareTrust REIT is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CareTrust REIT currently has a consensus price target of $43.92, indicating a potential upside of 20.22%. JAN has a consensus price target of $32.38, indicating a potential upside of 12.15%. Given CareTrust REIT's higher possible upside, equities analysts plainly believe CareTrust REIT is more favorable than JAN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareTrust REIT
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
JAN
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

In the previous week, JAN had 53 more articles in the media than CareTrust REIT. MarketBeat recorded 59 mentions for JAN and 6 mentions for CareTrust REIT. JAN's average media sentiment score of 1.68 beat CareTrust REIT's score of 0.41 indicating that JAN is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareTrust REIT
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
JAN
54 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

CareTrust REIT beats JAN on 10 of the 17 factors compared between the two stocks.

How does JAN compare to Alexandria Real Estate Equities?

JAN (NYSE:JAN) and Alexandria Real Estate Equities (NYSE:ARE) are both mid-cap real estate companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

JAN presently has a consensus target price of $32.38, suggesting a potential upside of 12.15%. Alexandria Real Estate Equities has a consensus target price of $50.86, suggesting a potential upside of 15.88%. Given Alexandria Real Estate Equities' higher possible upside, analysts clearly believe Alexandria Real Estate Equities is more favorable than JAN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JAN
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Alexandria Real Estate Equities
4 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.88

JAN has a net margin of 0.00% compared to Alexandria Real Estate Equities' net margin of -36.08%. JAN's return on equity of 0.00% beat Alexandria Real Estate Equities' return on equity.

Company Net Margins Return on Equity Return on Assets
JANN/A N/A N/A
Alexandria Real Estate Equities -36.08%-5.21%-2.92%

In the previous week, JAN had 56 more articles in the media than Alexandria Real Estate Equities. MarketBeat recorded 59 mentions for JAN and 3 mentions for Alexandria Real Estate Equities. JAN's average media sentiment score of 1.68 beat Alexandria Real Estate Equities' score of 0.23 indicating that JAN is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
JAN
54 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Alexandria Real Estate Equities
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

6.3% of JAN shares are owned by institutional investors. Comparatively, 96.5% of Alexandria Real Estate Equities shares are owned by institutional investors. 1.4% of Alexandria Real Estate Equities shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

JAN pays an annual dividend of $0.57 per share and has a dividend yield of 2.0%. Alexandria Real Estate Equities pays an annual dividend of $2.88 per share and has a dividend yield of 6.6%. Alexandria Real Estate Equities pays out -47.5% of its earnings in the form of a dividend. Alexandria Real Estate Equities has increased its dividend for 15 consecutive years. Alexandria Real Estate Equities is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

JAN has higher earnings, but lower revenue than Alexandria Real Estate Equities.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JAN$890.18M9.47$6.35MN/AN/A
Alexandria Real Estate Equities$3.03B2.53-$1.43B-$6.06N/A

Summary

JAN beats Alexandria Real Estate Equities on 10 of the 17 factors compared between the two stocks.

Get JAN News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAN vs. The Competition

MetricJANHealthcare REITs IndustryReal Estate SectorNYSE Exchange
Market Cap$8.39B$11.98B$5.16B$22.90B
Dividend Yield2.02%5.93%6.70%3.72%
P/E RatioN/A58.9527.2028.17
Price / Sales9.42107.52121.0120.91
Price / CashN/A22.9234.0537.05
Price / BookN/A1.691.734.67
Net Income$6.35M-$1.49M-$73.94M$1.07B
7 Day Performance3.36%0.58%-0.21%-0.67%
1 Month Performance-7.71%-4.23%-4.11%-4.30%
1 Year PerformanceN/A12.90%-6.66%5.52%

JAN Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAN
JAN
3.5826 of 5 stars
$28.41
-1.5%
$32.38
+14.0%
N/A$8.29B$890.18MN/A5
OHI
Omega Healthcare Investors
2.9304 of 5 stars
$44.39
+0.6%
$49.71
+12.0%
+14.5%$13.37B$1.28B15.8669
DOC
Healthpeak Properties
3.6175 of 5 stars
$18.80
+1.5%
$22.10
+17.5%
+5.6%$12.77B$2.82B53.72411
AHR
American Healthcare REIT
3.9012 of 5 stars
$50.77
+0.6%
$62.75
+23.6%
+27.2%$11.00B$2.26B74.66121
CTRE
CareTrust REIT
4.516 of 5 stars
$35.99
+0.6%
$44.25
+22.9%
+10.9%$8.46B$476.39M22.6443

Related Companies and Tools


This page (NYSE:JAN) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners